Arlington Partners LLC Novartis Ag Transaction History
Arlington Partners LLC
- $249 Million
- Q2 2025
A detailed history of Arlington Partners LLC transactions in Novartis Ag stock. As of the latest transaction made, Arlington Partners LLC holds 38,905 shares of NVS stock, worth $4.46 Million. This represents 1.89% of its overall portfolio holdings.
Number of Shares
38,905
Previous 40,882
4.84%
Holding current value
$4.46 Million
Previous $4.56 Million
3.29%
% of portfolio
1.89%
Previous 1.89%
Shares
10 transactions
Others Institutions Holding NVS
# of Institutions
1,539Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.35 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.19 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$986 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$808 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$775 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $246B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...